Bolger G B, Erdogan S, Jones R E, Loughney K, Scotland G, Hoffmann R, Wilkinson I, Farrell C, Houslay M D
Department of Veterans Affairs Medical Center, 151M, and Huntsman Cancer Institute, Department of Oncologic Sciences and Department of Medicine (Hematology/Oncology) University of Utah Health Sciences Center, Salt Lake City, UT 84148, USA.
Biochem J. 1997 Dec 1;328 ( Pt 2)(Pt 2):539-48. doi: 10.1042/bj3280539.
We have isolated and characterized complete cDNAs for two isoforms (HSPDE4D4 and HSPDE4A5) encoded by the human PDE4D gene, one of four genes that encode cAMP-specific rolipram-inhibited 3',5'-cyclic nucleotide phosphodiesterases (type IVPDEs; PDE4 family). The HSPDE4D4 and HSPDE4D5 cDNAs encode proteins of 810 and 746 amino acids respectively. A comparison of the nucleotide sequences of these two cDNAs with those encoding the three other human PDE4D proteins (HSPDE4D1, HSPDE4D2 and HSPDE4D3) demonstrates that each corresponding mRNA transcript has a unique region of sequence at or near its 5'-end, consistent with alternative mRNA splicing. Transient expression of the five cDNAs in monkey COS-7 cells produced proteins of apparent molecular mass under denaturing conditions of 68, 68, 95, 119 and 105 kDa for isoforms HSPDE4D1-5 respectively. Immunoblotting of human cell lines and rat brain demonstrated the presence of species that co-migrated with the proteins produced in COS-7 cells. COS-cell-expressed and native HSPDE4D1 and HSPDE4D2 were found to exist only in the cytosol, whereas HSPDE4D3, HSPDE4D4 and HSPDE4D5 were found in both cytosolic and particulate fractions. The IC50 values for the selective PDE4 inhibitor rolipram for the cytosolic forms of the five enzymes were similar (0.05-0.14 microM), whereas they were 2-7-fold higher for the particulate forms of HSPDE4D3 and HSPDE4D5 (0.32 and 0.59 microM respectively), than for the corresponding cytosolic forms. Our data indicate that the N-terminal regions of the HSPDE4D3, HSPDE4D4 and HSPDE4D5 proteins, which are derived from alternatively spliced regions of their mRNAs, are important in determining their subcellular localization, activity and differential sensitivity to inhibitors.
我们已经分离并鉴定了人类磷酸二酯酶4D(PDE4D)基因编码的两种亚型(HSPDE4D4和HSPDE4A5)的完整cDNA,PDE4D基因是编码环磷酸腺苷(cAMP)特异性咯利普兰抑制的3',5'-环核苷酸磷酸二酯酶(IV型磷酸二酯酶;PDE4家族)的四个基因之一。HSPDE4D4和HSPDE4D5 cDNA分别编码810和746个氨基酸的蛋白质。将这两个cDNA的核苷酸序列与编码其他三种人类PDE4D蛋白(HSPDE4D1、HSPDE4D2和HSPDE4D3)的序列进行比较,结果表明,每个相应的mRNA转录本在其5'-末端或附近都有一个独特的序列区域,这与可变mRNA剪接一致。在猴COS-7细胞中瞬时表达这五种cDNA,在变性条件下,HSPDE4D1-5亚型产生的蛋白质表观分子量分别为68、68、95、119和105 kDa。对人类细胞系和大鼠脑进行免疫印迹分析,结果表明存在与COS-7细胞中产生的蛋白质迁移率相同的条带。发现COS细胞表达的天然HSPDE4D1和HSPDE4D2仅存在于细胞质中,而HSPDE4D3、HSPDE4D4和HSPDE4D5则存在于细胞质和颗粒部分。选择性PDE4抑制剂咯利普兰对这五种酶细胞质形式的IC50值相似(0.05 - 0.14 microM),而对于HSPDE4D3和HSPDE4D5的颗粒形式,其IC50值分别为0.32和0.59 microM,比相应的细胞质形式高2 - 7倍。我们的数据表明,HSPDE4D3、HSPDE4D4和HSPDE4D5蛋白的N末端区域源自其mRNA的可变剪接区域,在决定它们在亚细胞中的定位、活性以及对抑制剂的不同敏感性方面具有重要作用。